Summary
The stock has recorded a trading volume of 5,30,594 shares,. Its Average Traded Price (ATP) is ₹71.13, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 45 @ ₹71.11.
Camlin Fine Sciences has an upper circuit limit of ₹86.58 and a lower circuit limit of ₹57.72. The total value traded stands at ₹3.77 CR, and the delivery percentage for the day is 47.48%.
The stock is currently traded with a market lot size of 1. Camlin Fine Sciences also offers a dividend yield of 0%.
Camlin Fine Sciences Share Price Chart
Camlin Fine Sciences Share Key Metrics
Volume
5.31 L
Market Cap
1366.00 CR
LTQ@LTP
45@71.11
ATP
71.13
Var Margin
28.35 %
Circuit Range
57.72-86.58
Delivery %
47.48 %
Value
3.77 CR
ASM/GSM
No
Market Lot
1
Camlin Fine Sciences Resistance and Support
Pivot 72.88
Resistance
First Resistance
73.76
Second Resistance
75.38
Third Resistance
76.26
Support
First Support
71.26
Second Support
70.38
Third Support
68.76
Camlin Fine Sciences Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2025-26
- 2024-25
- 2022-23
- 2023-24
- 2026-27
Total Promoters
Camlin Fine Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results & Rights issue |
| 2026-08-11 | Quarterly Results |
| 2026-05-26 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-09-29 | Preferential Issue of shares |
| 2025-05-23 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2025-01-02 | Others |
| 2024-11-22 | Rights issue of Equity Shares |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| Rights Date | Ratio | |
|---|---|---|
| 2025-01-08 | 5:41 | View More |
Camlin Fine Sciences News
Camlin Fine Sciences Ltd - 532834 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
Promoter Ashish S. Dandekar created a pledge on 3.7 lakh shares (0.19% of share capital) of Camlin Fine Sciences. The pledge was created in favor of Aditya Birla Capital to cover a shortfall in security margin cover.
Nov 13 2026 17:55:52
Camlin Fine Sciences Ltd - 532834 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Promoter Ashish Subhash Dandekar created an additional pledge on 3.70 lakh shares (0.19% stake) of Camlin Fine Sciences. The shares were pledged to Aditya Birla Capital to cover a margin shortfall in security cover.
Nov 13 2026 17:42:02
Camlin Fine Sciences Ltd - 532834 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
Promoter Ashish S. Dandekar pledged 10.80 lakh shares representing 0.56% of total share capital on 6 Nov 2026. The pledge was created in favour of SKS Fincap and Ashika Global Securities to cover a security shortfall for company borrowings.
Nov 09 2026 14:43:32
Camlin Fine Sciences Ltd - 532834 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Promoter Ashish Dandekar created a pledge on 10.80 lakh shares (0.56% of equity) on November 6, 2026. This was done as an additional margin pledge to cover the shortfall in security cover for financial assistance obtained by the company. Total encumbered shares now stand at 9.05%.
Nov 09 2026 14:41:42
Camlin Fine Sciences Ltd - 532834 - Board Meeting Outcome for Outcome Of Board Meeting
Camlin Fine Sciences reported a cons. net loss of ₹59.56 crores on revenue of ₹491.47 crores for the quarter ended September 2026. The board approved raising up to ₹250 crores through a rights issue and acknowledged a SEBI administrative warning letter.
Nov 03 2026 15:44:39
Camlin Fine Sciences Ltd - 532834 - Announcement Under Regulation 30 SEBI (LODR) Regulations - Receipt Of SEBI Administrative Warning Letter
Camlin Fine Sciences received an administrative warning letter from SEBI on October 30, 2026. The warning relates to the incorrect classification of certain promoter group members as public shareholders in filings between 2016 and 2023. The company has already rectified the error retrospectively with zero financial impact.
Oct 30 2026 17:07:09
Camlin Fine Sciences Ltd - 532834 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone And Consolidate Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026 And The Proposal For Raising Of Funds By Way Of Rights Issue Of Equity Shares.
Camlin Fine Sciences board will meet on 3 Nov 2026 for financial results and to evaluate a proposal for raising funds via rights issue. The fundraise may also involve the issuance of other securities subject to regulatory approvals.
Oct 29 2026 18:03:42
Camlin Fine Sciences Management
| Name | Position |
|---|---|
| Ashish Dandekar | Chairman & Managing Director |
| Harsha Raghavan | Non Independent & Non Executive Director |
Camlin Fine Sciences Similar Stocks
BN Agrochem Ltd.
14.65
-0.77 (4.99%)
Vidhi Specialty Food Ingredients Ltd.
306.95
2.55 (0.84%)
Oriental Aromatics Ltd.
428.35
-5.35 (1.23%)
Tinna Rubber And Infrastructure Ltd.
990.20
162.45 (19.63%)
Thirumalai Chemicals Ltd.
118.15
0.07 (0.06%)
DCW Ltd.
47.05
-0.20 (0.42%)
Meghmani Organics Ltd.
53.64
0.60 (1.13%)
Prakash Pipes Ltd.
222.00
7.23 (3.37%)
Krishana Phoschem Ltd.
242.11
0.29 (0.12%)
Camlin Fine Sciences FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in CAMLINFINE
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in CAMLINFINE
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade